Filing Details

Accession Number:
0000899243-21-030774
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-29 21:02:52
Reporting Period:
2021-07-27
Accepted Time:
2021-07-29 21:02:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1841387 Candel Therapeutics Inc. CADL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1494695 B Paul Manning C/O Candel Therapeutics, Inc.
117 Kendrick St., Suite 450
Needham MA 02494
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-27 36,000 $7.36 36,000 No 4 P Direct
Common Stock Acquisiton 2021-07-29 20,000 $7.30 56,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.31 to $7.40. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
  2. Shares held jointly with spouse.
  3. The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.855 to $7.80. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.